{
    "resourceType": "CodeSystem",
    "id": "research-study-phase",
    "meta": {
        "lastUpdated": "2022-01-02T02:17:18.597+11:00",
        "profile": [
            "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
        ]
    },
    "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      \n      <h2>ResearchStudyPhase</h2>\n      \n      <div>\n        \n        <p>Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.</p>\n\n      \n      </div>\n      \n      <p>This code system http://terminology.hl7.org/CodeSystem/research-study-phase defines the following codes:</p>\n      \n      <table class=\"codes\">\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">\n            \n            <b>Code</b>\n          \n          </td>\n          \n          <td>\n            \n            <b>Display</b>\n          \n          </td>\n          \n          <td>\n            \n            <b>Definition</b>\n          \n          </td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">n-a\n            \n            <a name=\"research-study-phase-n-a\"> </a>\n          \n          </td>\n          \n          <td>N/A</td>\n          \n          <td>Trials without phases (for example, studies of devices or behavioral interventions).</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">early-phase-1\n            \n            <a name=\"research-study-phase-early-phase-1\"> </a>\n          \n          </td>\n          \n          <td>Early Phase 1</td>\n          \n          <td>Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-1\n            \n            <a name=\"research-study-phase-phase-1\"> </a>\n          \n          </td>\n          \n          <td>Phase 1</td>\n          \n          <td>Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-1-phase-2\n            \n            <a name=\"research-study-phase-phase-1-phase-2\"> </a>\n          \n          </td>\n          \n          <td>Phase 1/Phase 2</td>\n          \n          <td>Trials that are a combination of phases 1 and 2.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-2\n            \n            <a name=\"research-study-phase-phase-2\"> </a>\n          \n          </td>\n          \n          <td>Phase 2</td>\n          \n          <td>Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-2-phase-3\n            \n            <a name=\"research-study-phase-phase-2-phase-3\"> </a>\n          \n          </td>\n          \n          <td>Phase 2/Phase 3</td>\n          \n          <td>Trials that are a combination of phases 2 and 3.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-3\n            \n            <a name=\"research-study-phase-phase-3\"> </a>\n          \n          </td>\n          \n          <td>Phase 3</td>\n          \n          <td>Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td style=\"white-space:nowrap\">phase-4\n            \n            <a name=\"research-study-phase-phase-4\"> </a>\n          \n          </td>\n          \n          <td>Phase 4</td>\n          \n          <td>Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.</td>\n        \n        </tr>\n      \n      </table>\n    \n    </div>"
    },
    "extension": [
        {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
            "valueCode": "brr"
        },
        {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
            "valueCode": "draft"
        },
        {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
            "valueInteger": 1
        }
    ],
    "url": "http://terminology.hl7.org/CodeSystem/research-study-phase",
    "identifier": [
        {
            "system": "urn:ietf:rfc:3986",
            "value": "urn:oid:2.16.840.1.113883.4.642.4.1247"
        }
    ],
    "version": "4.3.0-CIBUILD",
    "name": "ResearchStudyPhase",
    "title": "ResearchStudyPhase",
    "status": "draft",
    "experimental": false,
    "date": "2021-01-17T07:06:13+11:00",
    "publisher": "HL7 (FHIR Project)",
    "contact": [
        {
            "telecom": [
                {
                    "system": "url",
                    "value": "http://hl7.org/fhir"
                },
                {
                    "system": "email",
                    "value": "fhir@lists.hl7.org"
                }
            ]
        }
    ],
    "description": "Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.",
    "caseSensitive": true,
    "valueSet": "http://hl7.org/fhir/ValueSet/research-study-phase",
    "content": "complete",
    "concept": [
        {
            "code": "n-a",
            "display": "N/A",
            "definition": "Trials without phases (for example, studies of devices or behavioral interventions)."
        },
        {
            "code": "early-phase-1",
            "display": "Early Phase 1",
            "definition": "Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0."
        },
        {
            "code": "phase-1",
            "display": "Phase 1",
            "definition": "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients."
        },
        {
            "code": "phase-1-phase-2",
            "display": "Phase 1/Phase 2",
            "definition": "Trials that are a combination of phases 1 and 2."
        },
        {
            "code": "phase-2",
            "display": "Phase 2",
            "definition": "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks."
        },
        {
            "code": "phase-2-phase-3",
            "display": "Phase 2/Phase 3",
            "definition": "Trials that are a combination of phases 2 and 3."
        },
        {
            "code": "phase-3",
            "display": "Phase 3",
            "definition": "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug."
        },
        {
            "code": "phase-4",
            "display": "Phase 4",
            "definition": "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use."
        }
    ]
}